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T Cell-Independent, TLR-Induced IL-12p70 Production in
Primary Human Monocytes1
Isabelle Bekeredjian-Ding,2† Susanne Ilona Roth,2* Stefanie Gilles,* Thomas Giese,‡
Andrea Ablasser,* Veit Hornung,* Stefan Endres,* and Gunther Hartmann3§
IL-12p70 is a key cytokine for the induction of Th1 immune responses. IL-12p70 production in myeloid cells is thought to be
strictly controlled by T cell help. In this work we demonstrate that primary human monocytes can produce IL-12p70 in the
absence of T cell help. We show that human monocytes express TLR4 and TLR8 but lack TLR3 and TLR7 even after preincu-
bation with type I IFN. Simultaneous stimulation of TLR4 and TLR8 induced IL-12p70 in primary human monocytes. IL-12p70
production in peripheral blood myeloid dendritic cells required combined stimulation of TLR7/8 ligands together with TLR4 or
with TLR3 ligands. In the presence of T cell-derived IL-4, but not IFN-, stimulation with TLR7/8 ligands was sufficient to
stimulate IL-12p70 production. In monocytes, type I IFN was required but not sufficient to costimulate IL-12p70 induction by
TLR8 ligation. Furthermore, TLR8 ligation inhibited LPS-induced IL-10 in monocytes, and LPS alone gained the ability to
stimulate IL-12p70 in monocytes when the IL-10 receptor was blocked. Together, these results demonstrate that monocytes are
licensed to synthesize IL-12p70 through type I IFN provided via the Toll/IL-1R domain-containing adaptor inducing IFN-
pathway and the inhibition of IL-10, both provided by combined stimulation with TLR4 and TLR8 ligands, triggering a potent
Th1 response before T cell help is established. The Journal of Immunology, 2006, 176: 7438–7446.
M onocytes circulate in the blood stream (mainlyCD14CD16 monocytes) and migrate to inflamma-tory sites (mainly CD14CD16 monocytes) (1).
They contribute to immune responses in two ways: 1) in the pres-
ence of maturation stimuli, monocytes differentiate into dendritic
cells (DCs)4 and thereby specialize in Ag presentation; and 2)
because of their high frequency (4–6% of blood leukocytes),
monocytes also represent a major source of cytokines that modu-
late innate and adaptive immune responses. An excessive stimu-
lation of these cells is associated with a high local or systemic
toxicity as has been described in rheumatoid arthritis and sepsis (2,
3), highlighting the importance of studying the exact mechanisms
leading to monocyte activation and subsequent cytokine secretion.
IL-12 is secreted by innate immune cells and has been shown to
directly and indirectly regulate T and B cell responses. Its main
function is the induction of IFN- in both T cells and NK cells,
thereby supporting a Th1 response (4–6). IL-12 synergizes with
polyclonal T cell activators (5, 7, 8) and indirectly regulates B cell
Ig isotype switching through its direct effects on T cell cytokine
expression (9).
IL-12 is mainly secreted by cells of the monocyte/macrophage
lineage; minor sources of IL-12 are B cells and plasmacytoid DCs
(PDCs) receiving T cell help (10–12). IL-12 consists of a p35
subunit and a p40 subunit that form the biologically active het-
erodimer IL-12p70. Although IL-12p35 mRNA is ubiquitously ex-
pressed, inflammatory cells display only low levels of p35 mRNA
(13). Secretion of p35 protein is even more strictly controlled and
occurs only after heterodimerization with IL-12p40. Because the
p40 subunit is abundantly expressed, it has been proposed that the
heterodimerization itself may be regulated by posttranscriptional
mechanisms (13–16). This implies that IL-12p70 release is limited
to well-defined biological settings. In view of the key function of
biologically active IL-12, it is of special interest to study the bio-
logical mechanisms leading to its secretion. To date, primary
monocytes have been shown to produce IL-12p70 after stimulation
with inactivated whole Gram-positive bacteria and in response to
LPS with Th cell costimulation through IFN- or CD40L (17–20).
TLRs are a subgroup of pattern recognition receptors (PRRs)
characterized by two main structural elements: 1) the leucine-rich
repeats in the N-terminal domain that are involved in the recog-
nition and binding of the ligand; and 2) the C-terminal Toll/IL-1R
domain that is crucial for downstream signal transduction (21). As
PRRs, TLRs recognize specific molecular motifs present in micro-
bial cell walls or nucleic acids. LPS (endotoxin) that is expressed
on the cell walls of Gram-negative bacteria is the ligand for TLR4.
TLR2 ligands comprise a variety of lipoproteins expressed in bac-
terial cell walls. RNA molecules represent the natural ligands for
TLR7 and TLR8 (22–25). Two main TLR signaling pathways are
known to date. The first, common to all TLRs, is signaling through
the scaffold adaptor molecule MyD88, and the second, only de-
scribed for TLR3 and TLR4, is through activation of Toll/IL-1R
domain-containing adaptor inducing IFN- (TRIF) (21, 26–28).
Both pathways lead to NF-B and MAPK activation. Signaling
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through TRIF by TLR3 and TLR4 differs in the time frame of
NF-B activation, IFN regulatory factor 3 phosphorylation, and
subsequent IFN- synthesis. Information about the synergistic or
additive effects of parallel stimulation of different TLRs is limited.
To date, the synergies of TLR2 with dectin-1, TLR4 with Nod1/2,
DC-specific ICAM-3-grabbing nonintegrin (DC-SIGN) with
TLR4, adenosine A2A receptor with TLR2, TLR4, TLR7, and
TLR8, and TLR4 with TLR7/8 have been described in different
cell types (29–34). These studies indicate that synergies of differ-
ent PRRs may represent subtle means for regulating cell type-
specific responses in innate immune defense.
In the present study we hypothesized that such synergies may
license primary human monocytes to produce IL-12p70. We found
that among a number of different TLR agonists only the combi-
nation of a TLR8 ligand with a TLR4 ligand can license primary
monocytes to produce IL-12p70. The TLR4-TLR8 synergism in-
volves the induction of type I IFN and a dose-dependent inhibition
of TLR4-induced IL-10 secretion.
Materials and Methods
Isolation and culture of monocytes and myeloid DCs (MDCs)
Human PBMCs were prepared by Ficoll-Hypaque density gradient cen-
trifugation (Biochrome) of heparinized blood from healthy volunteers
(aged 23–47). Monocytes and MDCs were isolated by MACS. Untouched
monocytes were prepared in a step-by-step protocol by depleting PDCs
with anti-BDCA-4 microbeads, T cells with anti-CD3 microbeads, B cells
with anti-CD19 microbeads, MDCs with anti-BDCA-1 microbeads, and
NK cells with anti-CD16 and anti-CD56 microbeads. Monocytes were
identified as CD14, HLA-DR, CD11c, CD4low, CD16, CD123,
CD3, CD8, CD56, and CD34 cells. The purity of isolated monocytes
(CD11cHLA-DRCD14) was 96%  SEM (2%). If only MDCs, but
not monocytes, were isolated from PBMCs, MDCs were positively se-
lected with anti-BDCA-1 microbeads after depletion of PDCs with anti-
BDCA-4, monocytes with anti-CD14, and B cells with anti-CD19 mi-
crobeads. All microbeads were purchased from Miltenyi Biotec. MDC
purity was 97  2%. Cells were cultured in RPMI 1640 (Biochrom) sup-
plemented with 2% autologous serum, 10 mM HEPES (from Sigma-
Aldrich), 1.5 mM L-glutamine, 100 U/ml penicillin, and 100 g/ml strep-
tomycin (all from PAA Laboratories) in 96-well round-bottom plates at a
concentration of 2.5  105 monocytes/0.2 ml/well and 5  104 MDCs/0.2
ml/well, respectively. Supplemented medium (except autologous serum
which was added separately) was tested as being free of endotoxin (lack of
TNF- induction in monocytes) (35). PBMCs were cultured at 0.4  106
cells/0.2 ml/well under the same conditions.
Generation of monocyte-derived DCs (MoDCs)
Monocyte-derived DCs were generated from monocytes isolated from PB-
MCs by adherence to plastic. PBMCs were prepared as described above
and resuspended in a density of 5  106 cells/ml in DC medium. DC
medium was RPMI 1640 (Biochrom) supplemented with 2% (v/v) pooled
human AB serum (BioWhittaker), 1.5 mM L-glutamine, 100 U/ml penicil-
lin, and 100 g/ml streptomycin. Twenty milliliters of the cell suspension
were filled into one 750-ml cell culture flask and incubated at 37°C and 5%
CO2. After 1 h, nonadherent cells were removed, and remaining cells were
washed twice with 0.9% NaCl solution. Adherent cells were then resus-
pended in fresh DC medium, harvested with a cell scraper after 24 h,
washed, and purity analyzed by flow cytometry (95–98% CD14). Mono-
cytes were cultured at 5  105 cells/ml in DC medium supplemented with
1000 U/ml recombinant human (rh) GM-CSF (Immunex) and 500 U/ml
rhIL-4 (Promega), 500 U/ml rhIFN-, or rhIFN- (PeproTech), respec-
tively. On day 5, an aliquot of the immature MoDCs was analyzed by flow
cytometry. MoDCs generated with GM-CSF/IL-4 were CD14, CD80low,
CD83, and CD86. Cells cultured with GM-CSF/IFN- were CD14low,
CD80low, CD83, and CD86. Day 5 MoDCs were resuspended at 5 
105 cells/ml in flat-bottom, 96-well plates.
Stimulation of cells
All TLR ligands were titrated to define optimal stimulating conditions in
the different cell types analyzed in the study. Cells were stimulated with
LPS from Escherichia coli (0.1 and 1 g/ml; Sigma-Aldrich), R848 (0.25,
0.5, 2.5, and 5 g/ml; InvivoGen), Pam3CSK4 (50, 200, and 1000 ng/ml;
InvivoGen), macrophage-activating lipopeptide-2 (MALP-2; 2.5, 5, and
1000 ng/ml; Alexis Biochemicals), poly(I:C) (100 g/ml; Sigma-Aldrich),
and loxoribine (500 M; Sigma-Aldrich). All TLR ligands were resus-
pended in endotoxin-free water (aqua ad injectabilia) except LPS, which
was resuspended in medium. Poly(I:C) was subjected to 10 precipitations
and washes in ethanol to remove endotoxin. The stepwise purification pro-
cess was documented by a gradual loss of activity to induce TNF- in
PBMCs. The final preparation of poly(I:C) used throughout the study did
not induce intracellular TNF- in monocytes (highly sensitive endotoxin
assay) (35) or detectable levels of TNF- in PBMCs but still activated
TLR3-expressing MDCs.
For CD40 ligation, baby hamster kidney (BHK)-CD40L and BHK-
pTCF (neomycin-resistant, mock-transfected control cell line) were pro-
vided by H. Engelmann (University of Munich, Munich, Germany) and UV
irradiated at 0.75 J/cm2. IFN- (100 and 1000 U/ml as indicated), IFN-
(100 U/ml) (both from Strathmann Biotech), and IFN- (1000 U/ml;
Roche) were added simultaneously or 1 h before monocyte or MDC stim-
ulation. For the blockade of IL-10, monocytes were preincubated with Fc
block (Miltenyi Biotech) for 10 min, washed, resuspended and then pre-
incubated with anti-IL-10 and anti-IL-10R neutralizing mAbs (mouse anti-
human IL-10, catalog no. MAB217, and IL-10R-, catalog no. MAB274;
R&D Systems) at a final concentration of 10 g/ml for 1 h before stimu-
lation. For IFN-R blocking experiments, monocytes were incubated with
Fc block and then preincubated with either neutralizing anti-IFN-R mAb
(mouse anti-human IFN  receptor chain 2, catalog no. 21385-1; PBL
Biomedical Laboratories) or non-neutralizing anti-IFN-R Ab (rabbit anti-
human IFN  receptor chain 2, catalog no. 31385-1; PBL Biomedical
Laboratories) at 20 g/ml for 1 h before stimulation. MoDCs were stim-
ulated with 2.5 g/ml R848 or 500 M loxoribine with or without simul-
taneous addition of LPS (0.1 g/ml).
Detection of cytokines
Monocyte supernatants were harvested 24 h after stimulation unless indi-
cated otherwise. Supernatants from MDCs were harvested after 24 h, and
supernatants from MoDCs were analyzed after 48 h. IL-12p70, IL-12p40,
IL-10, IFN-, and TNF- concentrations in the cell supernatants were mea-
sured by ELISA. All ELISA Ab pairs were purchased from BD Bio-
sciences, and the protocols were performed according to the manufactur-
er’s recommendations. The IFN- ELISA was purchased from Bender
MedSystems.
Flow cytometry
Flow cytometric data were obtained on a FACSCalibur flow cytometer and
analyzed with CellQuest software (BD Biosciences). Staining was per-
formed following standard procedures. The mAbs used anti-CD14 (FITC),
anti-HLA-DR (PerCP), anti-CD11c (allophycocyanin), anti-CD4 (PE), anti-
CD8(allophycocyanin), anti-CD80(PE),anti-CD86(allophycocyanin), anti-
CD83 (FITC), anti-CD123 (PE), anti-CD3 (FITC), anti-CD3 (allophyco-
cyanin), anti-CD56 (PE), anti-CD16(FITC), anti-CD34 (allophycocyanin),
anti-CD19 (PE), and TNF- (PE) (all from BD Pharmingen), as well as
anti-BDCA-2 (FITC) from Miltenyi Biotec.
RNA isolation, cDNA synthesis, and quantitative real-time PCR
For RNA preparation cells were washed with 0.9% NaCl, and cell pellets
were lysed in 300 l of lysis buffer from the MagnaPure LC mRNA iso-
lation kit I supplemented with 1% DTT (Roche) and frozen at 80°C until
further handling. Preparation of mRNA was performed with the Magna-
Pure-LC device using the mRNA-I standard protocol. An aliquot of 8.2 l
of RNA was reverse-transcribed using avian myeloblastosis virus-reverse
transcriptase and oligo(dT) as primer (First Strand cDNA synthesis kit;
Roche) according to the manufacturer’s protocol in a thermocycler. The
reaction mix was diluted to a final volume of 0.5 ml and stored at 20° C
until PCR analysis.
Parameter-specific primer sets optimized for the LightCycler (Roche)
were developed and purchased from SEARCH-LC. The PCR was per-
formed with the LightCycler FastStart DNA SYBR Green I kit (Roche)
according to the protocol provided in the parameter-specific kits. The tran-
script numbers were normalized according to the expression of cyclophilin
B and -actin per microliter of cDNA.
Statistical analysis
Data are depicted as mean  SEM. Statistical significance of differences
was determined by paired two-tailed Student’s t test using Microsoft Excel
software. Statistically significant differences are indicated with  for p 
0.05 and  for p  0.005.
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Results
Primary human CD14CD16 monocytes express functional
TLR4 and TLR8 but not TLR7
To study IL-12p70 production in human primary monocytes we
isolated untouched resting (CD14CD16) monocytes as de-
scribed in Materials and Methods and schematically explained in
Fig. 1. The purity achieved by this negative selection method was
96 2% (Fig. 1), with no CD16 monocytes detectable in the cell
preparation. Of note, in stimulated monocyte preparations IFN-
was below the detection limit, confirming the absence of T cells
and NK cells. All experiments were conducted with autologous
serum to avoid endotoxin exposure of monocytes.
To address expression and function of TLRs and Nods, we first
analyzed their mRNA expression as shown in Fig. 2A. Monocytes
expressed low levels of TLR8, intermediate levels of Nod-2, high
levels of TLR2 and TLR4, and no Nod-1 or TLR3 mRNA. Type
I IFN has previously been shown to enhance mRNA de novo syn-
thesis of TLR7 in human B cells (36). In contrast with B cells, in
monocytes we found that neither recombinant IFN- (Fig. 2A) nor
IFN- (data not shown) failed to up-regulate TLR7 or any other
PRRs studied, including TLR4. In contrast, MyD88, a well-known
IFN-inducible gene, was up-regulated and thus served as a positive
control for IFN-I stimulation.
Next, human monocytes were stimulated with the TLR7/8 ag-
onist R848, the TLR7 agonist loxoribine, and the TLR4 agonist
LPS. After 24 h the cell surface expression levels of HLA-DR and
CD80 were quantified (Fig. 2B). Despite the low expression of
TLR8 mRNA, R848 potently activated human monocytes compa-
rable to the way LPS did. In contrast, loxoribine failed to induce
the expression of HLA-DR and CD80. In B cells, TLR7 sensitivity
is known to be strongly enhanced by the addition of IFN-. We
stimulated monocytes in the presence and absence of IFN-. In
contrast to B cells, type I IFN did not enhance the sensitivity of
human monocytes toward R848 and loxoribine (Fig. 2B). For lox-
oribine, expression of HLA-DR and CD80 slightly below the me-
dium control may be due to a TLR-independent toxic effect of
loxoribine. Similar to HLA-DR and CD80, TNF- and IL-12p40
in the monocyte supernatants were not altered by costimulation
with IFN-I (data not shown). Together, these data indicated that
TLR8 and TLR4, but not TLR7, are functional in primary human
monocytes.
TLR8 and TLR4 synergize to induce IL-12p70 production in
human monocytes
Recent data suggest that TLR7/8 and TLR4 synergize in the acti-
vation of murine and human dendritic cells (33, 34). Because
monocytes express functional TLR8 but not TLR7, monocytes
were used as an experimental system to study a possible synergy
between TLR8 and TLR4. R848 in monocytes represents a selec-
tive TLR8 stimulus because functional TLR7 is absent.
We found that only the combination of TLR4 and TLR8 ago-
nists induced significant IL-12p70 production (Fig. 3), whereas
TNF- and IL-12p40 were also produced in response to single
TLR ligation. Consistent with the absence of functional TLR7 on
primary monocytes, the selective TLR7 ligand loxoribine failed to
induce TNF- and IL-12p40 as well as IL-12p70 production when
combined with LPS (Fig. 4). Together, these data indicated that
IL-12p70 production in primary human monocytes is under the
combined control of TLR8 and TLR4.
Failure of TLR2 ligands to synergize with R848 or LPS for
IL-12p70 production in human monocytes
Because TLR4 activation by LPS is confined to Gram-negative
pathogens, we wanted to know whether the pathogen-associated
molecular patterns typically associated with Gram-positive patho-
gens would also induce IL-12p70 production as seen with LPS. We
stimulated human monocytes with the TLR2-activating bacterial
lipopeptides (MALP-2 and Pam3CSK4) alone or in combination
with R848 or LPS.
Monocytes produced TNF- and IL-12p40 in response to
MALP-2, Pam3CSK4, R848, and LPS (Fig. 4). The TLR3 ligand
poly(I:C) failed to induce TNF- and IL-12p40 as expected be-
cause of a lack of TLR3 mRNA expression (data not shown). No
synergistic TNF- or IL-12p40 induction was observed for TLR2
ligands in combination with either LPS or R848 (Fig. 4). None of
the combinations of TLR2 ligands with R848 or LPS induced IL-
12p70 secretion. Furthermore, the Nod2 ligand muramyl dipeptide
did not synergize with R848 (data not shown). As expected, IL-
12p70 secretion was also seen for the combination of R848 with
the Th cell stimulus CD40L (Fig. 4), but not when R848 was
combined with IFN- (data not shown).
TLR-induced IL-12p70 production in BDCA-1 MDCs
Next, we studied TLR expression and IL-12p70 induction in pe-
ripheral blood MDCs. MDCs were found to express TLR2, TLR3,
TLR4, and TLR8 (Fig. 5A). Furthermore, TLR7 was up-regulated
when MDCs were incubated for 3 h with IFN- (Fig. 5A). The
TLR7/8 ligand R848 induced IL-12p70 production only in com-
bination with the TLR4 ligand LPS or the TLR3 ligand poly(I:C),
FIGURE 1. Isolation of monocytes from human PBMC. Untouched
monocytes were isolated by the initial depletion of PDCs and T cells with
Ab-coated anti-BDCA-4 and anti-CD3 microbeads and the subsequent de-
pletion of B cells, NK cells, and MDCs with anti-CD19, anti-CD56, anti-
CD16, and anti-BDCA-1 microbeads. The monocytes obtained by this
method were CD14CD16 and had a purity of 96  2%.
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but not with the TLR2 ligands PAM3CSK4 and MALP-2 (Fig. 5B).
For the TLR7 ligand loxoribine, IL-12p70 production was only
found when TLR7 expression was up-regulated by IFN- and
when the TLR7 ligand loxoribine was combined with LPS (Fig.
5B). Of note, the TLR3 ligand poly(I:C) alone was sufficient to
induce IL-12p70 in MDCs (Fig. 5B), whereas poly(I:C) was not
functional in isolated monocytes lacking TLR3 (TNF- production
in monocytes (pg/ml) with poly(I:C), 0; LPS at 1 g/ml: 3961;
mean of four independent experiments). Together, these data in-
dicate that, in contrast to monocytes, MDCs express functional
TLR3 and, in the presence of IFN-, start to express functional
TLR7; furthermore, the data show that in both monocytes and
MDCs the TLR7/8 ligand R848 alone was not sufficient to induce
IL-12p70. The requirement for combined stimulation with R848
and LPS for IL-12p70 induction was confirmed in mixed cell pop-
ulations (PBMC) containing both monocytes and MDCs (IL-
12p70 production in PBMC (pg/ml) with R848, 0; LPS at 100
ng/ml, 0; LPS at 1 g/ml, 0; R848 plus LPS at 100 ng/ml, 54;
R848 plus LPS at 1 g/ml, 76). Similar to isolated monocytes and
MDCs, for TNF- no synergy was found in PBMC (TNF- in
PBMC (pg/ml) with R848, 3537; LPS at 100 ng/ml, 987; LPS at 1
g/ml, 1328; R848 plus LPS at 100 ng/ml, 2827; R848 plus LPS
at 1 g/ml, 2579; mean of four independent experiments). It is
important to note that in PBMC IL-12p70 was induced by R848
alone when cells were incubated in medium containing FCS in-
stead of autologous serum (autologous serum used throughout this
study) (I. Bekeredjian-Ding, unpublished observation). FCS, but
not autologous serum, leads to nonspecific costimulation of im-
mune cells.
IL-12p70 production in MDCs generated in GM-CSF and IL-4
or GM-CSF and IFN-I
The comparison of MoDCs generated with GM-CSF plus IL-4 or
GM-CSF plus IFN- or IFN- revealed a striking difference (Fig.
6). Although MoDCs generated in the presence of GM-CSF and
IL-4 (Th cell-derived cytokine) readily secreted IL-12p70 in re-
sponse to R848 or LPS alone, MoDCs generated in the presence of
GM-CSF and type I IFN (data for GM-CSF plus IFN- not
shown), similarly to monocytes and peripheral blood MDCs, re-
quired combined stimulation with R848 and LPS. Interestingly, the
selective TLR7 agonist loxoribine induced IL-12p70 release when
combined with LPS in both MoDC cell types, indicating the pres-
ence of functional TLR7 in MoDCs (Fig. 6).
FIGURE 2. Influence of type I IFN on TLR mRNA
expression and the influence of TLR-induced cell sur-
face expression of activation markers on human mono-
cytes. A, PRR mRNA expression. Purified monocytes
(0.5  106 cells) were cultured in medium with 2%
autologous serum in the presence and absence of IFN-
(IFNb) (100 U/ml) for 3 h before mRNA extraction.
mRNA expression of PRRs was determined by quanti-
tative real-time RT-PCR. IFN--inducible MyD88
mRNA expression served as a positive control for
IFN- stimulation. Results are presented as mean tran-
script numbers of adjusted transcripts per microliter of
cDNA SEM of five individual donors. B, Cell surface
expression of activation markers after TLR4, TLR7, and
TLR8 stimulation in the presence and absence of IFN-.
Monocytes (1.25 106/ml) were incubated with LPS (1
g/ml), R848 (2.5 g/ml), or loxoribine (0.5 mM) in the
presence and absence of IFN- (100 U/ml). HLA-DR
and CD80 surface expression were measured after 24 h
by FACS analysis. Unfilled histograms represent the un-
stimulated control. One representative experiment of at
least three is shown.
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Type I IFN is required for IL-12p70 production in monocytes
Recently, it has been postulated that autocrine IFN- secretion is
crucial for IL-12p70 production from murine bone marrow-de-
rived dendritic cells (33). To assess the role of type I IFN in mono-
cytes, monocytes were stimulated with R848 or LPS in the pres-
ence or absence of exogenous type I IFN. We found that priming
or simultaneous incubation with recombinant IFN-I did not en-
hance TNF-, IL-12p40, or IL-12p70 production in response to
R848 or LPS (data not shown).
Subsequently, we examined monocyte-derived IL-12p70 secre-
tion in monocytes stimulated with LPS plus R848 in the presence
of IFN-R-blockade. As shown in Fig. 7, treatment of monocytes
with neutralizing anti-IFN-R Ab abolished the IL-12p70 release.
These data indicated that, in monocytes, autocrine type I IFN pro-
duction is required for IL-12p70 secretion upon synergistic acti-
vation with LPS and R848 but that it is not sufficient to costimulate
IL-12p70 production in response to single TLR-mediated stimu-
lation as shown above.
R848 inhibits LPS-induced IL-10 production in monocytes
To further define the mechanisms responsible for the synergy of
R848 and LPS leading to IL-12p70 production, we analyzed the
mRNA expression in human monocytes stimulated with R848 or
LPS. We found that both R848 and LPS up-regulated TLR4,
MyD88, TRIF, and IP-10 expression (mRNA expression, adjusted
transcripts per microliter of cDNA  SEM: unstimulated control
TLR4, 60  5; MyD88, 46  10; TRIF, 33  2; IP-10, 13  5;
LPS TLR4, 139  25; MyD88, 78  20; TRIF, 85  16; IP-10,
310  139; R848 TLR4, 110  10; MyD88, 85  10; TRIF,
146  21; IP-10, 561  193). Although up-regulation of TLR4,
MyD88, and TRIF mRNA may contribute to synergistic IL-12p70
induction, the functional contribution of increased mRNA levels to
the observed effects is uncertain. Another candidate mechanism is
the regulation of IL-10, which is well known to suppress IL-12
production, especially IL-12p70. We found that, despite higher
TNF- and IL-12p40 induction, R848 induced much less IL-10
than LPS (Fig. 8). Furthermore, we observed a dose-dependent
inhibition of LPS-induced IL-10 production by R848 (Fig. 8, A and
B). This effect was dependent on simultaneous stimulation with
LPS and R848, because inhibition of LPS-induced IL-10 produc-
tion was much lower when R848 was added 1 or 4 h after LPS
(data not shown).
Blocking of IL-10 enables single TLR-mediated induction of
IL-12p70 in monocytes
To confirm a key role for IL-10, we performed IL-10 blocking
experiments. Monocytes were treated with anti-IL-10 and anti-IL-
10R Abs 1 h before TLR stimulation. We found that when func-
tional IL-10 was blocked, both R848 and LPS alone were able to
induce IL-12p70; furthermore, synergistic IL-12p70 induction by
FIGURE 3. R848- and LPS-induced cytokine expression on monocytes.
Purified monocytes (1.25  105/ml) were stimulated with LPS (1 g/ml),
R848 (2.5 g/ml), or LPS (1 g/ml) plus R848 (2.5 g/ml) for 24 h.
IL-12p40 (a), TNF- (b), and IL-12p70 (c) concentrations in the superna-
tants were measured by ELISA. Data from nine independent experiments
are shown as means  SEM. Analysis of IL-12p70 secretion revealed a
significant donor variability, but IL-12p70 production after R848 stimula-
tion alone was detectable in only one donor as shown in d. , p  0.001.
FIGURE 4. Cytokine production of PRR-stimulated monocytes. Puri-
fied monocytes (1.25  106/ml) were stimulated for 24 h with the PRR
ligands indicated below. Cytokine secretion was determined in the super-
natants by ELISA. The means SEM of four independent experiments are
summarized. Cells were incubated with LPS (1 g/ml), R848 (2.5 g/ml),
LPS plus R848, loxoribine (0.5 mM), loxoribine plus LPS, or with
MALP-2 (1 g/ml), Pam3CSK4 (1 g/ml), or UV-irradiated BHK-CD40L
or BHK-pTCF cells alone or in combination with LPS or R848. Values of
individual donors are normalized because of high donor variability with
R848 plus LPS representing 100% of cytokine secretion. One hundred
percent corresponds to 56  54 pg/ml for IL-12p70 (top panel), 1869 
804 pg/ml for IL-12p40 (middle panel), and 9686  916 pg/ml for TNF-
(bottom panel).
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R848 and LPS was further enhanced (Fig. 8C). Based on these
results, we conclude that IL-12p70 secretion from LPS- and R848-
stimulated human monocytes is prevented by autocrine release of
IL-10 and that R848 supports LPS-induced IL-12p70 production
by reducing LPS-induced IL-10 secretion.
Discussion
In the literature a number of stimuli have been described that en-
hance both IL-12p35 and IL-12p40 secretion (14, 15, 37–39), and
it is well established that T cell-derived cytokines license myeloid
cells for the secretion of the bioactive heterodimer of IL-12p35 and
IL-12p40, IL-12p70. Human monocytes have been shown to pro-
duce IL-12p70 upon microbial stimulation in the presence of T cell
help mediated through either cell-cell interaction via CD40-
CD40L or by costimulation with T cell-derived IFN-. To our
knowledge, it has not been demonstrated that IL-12p70 production
in human monocytes can occur in the absence of T cell help or
factors derived from activated NK cells. In this study we demon-
strate for the first time that primary human monocytes, upon ap-
propriate microbial stimulation, can become a considerable source
of IL-12p70 production in the absence of T cell help. We demon-
strate that, for monocytes, the only appropriate combination of
microbial stimuli that licenses monocytes to produce IL-12p70 is
simultaneous stimulation with TLR4 and TLR8 ligands.
There have been reports showing that whole bacteria have the
potential to induce IL-12p70 production in monocytes (18, 19).
The exact mechanism leading to IL-12p70 release after stimulation
with these microbes is, to date, unclear. The data presented in this
study suggest that the secretion of IL-12p70 from human mono-
cytes in the absence of T cell help is controlled by ligation of
TLR4 in combination with TLR8. This double requirement may
FIGURE 7. Effect of IFNR blockade on monocyte-derived IL-12p70
secretion. Monocytes (1.25  106/ml) were preincubated with a neutral-
izing IFN-R Ab (aIFNR) or a non-neutralizing IFN-R Ab (aIFNRnn) in
the concentration of 20 g/ml for 1 h before addition of R848 in the final
concentration of 2.5 g/ml and LPS at 1 g/ml. Results from three exper-
iments are summarized and shown as means  SEM. Data are normalized,
with 100% representing the cytokine concentration after stimulation with
R848 plus LPS in the presence of the non-neutralizing IFN-R Ab. One
hundred percent corresponds to 80  67 pg/ml IL-12p70, 2549  337
pg/ml IL-12p40, and 7147  797 pg/ml for TNF-. , p  0.025 for
IL-12p70.
FIGURE 5. PRR expression and IL-12p70 production in myeloid den-
dritic cells. MDCs were positively isolated using anti-BDCA-1 microbeads
as described above. A, Analysis of PRR mRNA expression. Purified MDCs
(2.5 105 cells) were incubated with (u) or without (f) IFN- (IFNa; 100
U/ml) for 3 h before isolation of mRNA. PRR mRNA expression was
measured by quantitative real-time RT-PCR. Results of four independent
experiments are shown as mean transcript numbers of adjusted transcripts
per microliter of cDNA  SEM. B, IL-12p70 production after stimulation
with TLR ligands. Purified MDCs (2.5  105/ml) were stimulated with
LPS (1 g/ml), loxoribine (Lox; 0.5 mM), IFN- (IFNa; 1000 U/ml), R848
(2.5 g/ml), Pam3CSK4 (1 g/ml), MALP-2 (1 g/ml), and poly(I:C) (100
g/ml) or combinations of these substances as indicated. After 24 h the
concentration of IL-12p70 in the supernatants was determined by ELISA.
Results are presented as means SEM from five individual donors. , p
0.01; , p  0.0005.
FIGURE 6. IL-12p70 production in MoDCs. MoDCs generated with
GM-CSF plus IL-4 (left panel) and GM-CSF plus IFN- (right panel) were
compared after stimulation with R848 (2.5 g/ml) or loxoribine (0.5 mM)
in the presence () or absence () of LPS (0.1 g/ml). Means  SEM of
four independent experiments are shown.
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represent a safeguard mechanism preventing inappropriate secre-
tion of this potentially harmful key Th1 cytokine in the early phase
of an infection when T cell help is not yet established.
At first sight, the amount of IL-12p70 released by primary hu-
man monocytes seems relatively low compared with MDC that
produce 40-fold higher amounts of IL-12p70 on a per-cell basis.
However, peripheral blood contains 20 times more monocytes
than MDC, and, therefore, the total amount of IL-12p70 produced
by monocytes is significant.
Our results obtained in monocytes and primary blood MDCs
differed from those obtained in MoDCs generated in the presence
of GM-CSF and IL-4 in which single TLR stimulation was suffi-
cient for IL-12p70 induction. Because IL-4 belongs to the T cell-
derived cytokines costimulating IL-12p70 secretion (17, 40), the
presence of IL-4 in MoDC cultures may account for their low
stimulatory threshold for IL-12p70 production. Consequently,
MoDCs generated in the presence of GM-CSF and IL-4 may not
represent an adequate experimental system for studying the induc-
tion of IL-12p70 in the physiological myeloid cell compartment.
The dual requirement for a TLR4 ligand and a TLR8 ligand for
IL-12p70 production in monocytes in our study highlights the re-
quirement to perform studies on IL-12p70 under endotoxin-free
conditions. Other reports that describe IL-12p70 production in re-
sponse to single TLR stimulation may need to be revisited under
this aspect. In this context it is important to note that the primary
human monocyte is one of the most LPS-sensitive cell types
known. Therefore, we used autologous serum from the same donor
and not FCS in our experimental setting throughout the study.
Even the FCS that tested as endotoxin-negative in the standard
Limulus amebocyte lysate assay in our hands still induces TNF-
in PBMC (I. Bekeredjian-Ding, unpublished observation). As a
consequence, PBMC were found to produce IL-12p70 upon stim-
ulation with R848 alone when FCS was used instead of autologous
serum (I. Bekeredjian-Ding, unpublished observation).
Interestingly, combined stimulation via TLR8 and TLR4 may
also play a role for the activation of myeloid cells by certain vi-
ruses. For example, the respiratory syncytial virus has been shown
to activate immune cells through a TLR4-dependent mechanism
and was shown to induce IL-12p70 production in human myeloid
cells (41). Other viruses may induce IL-12p70 via dual engage-
ment of TLR3 and TLR7 or TLR8 (42, 43). According to our
results, this will not occur in monocytes lacking TLR3 but is ex-
pected in MDCs expressing TLR3.
FIGURE 8. Role of IL-10 for IL-12p70 production
in human monocytes. Monocytes (1.25  106/ml) were
incubated with LPS, R848, LPS plus R848, or medium
alone in the concentrations indicated in the diagrams.
Cytokine concentrations in the supernatants after 24 h of
stimulation were measured by ELISA. A, IL-10 secre-
tion. Data from three independent experiments are sum-
marized as means  SEM. B, Comparison of monocyte
IL-12p40 (upper left), TNF- (lower left), IL-12p70
(upper right), and IL-10 (lower right) secretion. The
means  SEM of three independent experiments are
shown. C, Effect of IL-10- or IL-10R-blockade on IL-
12p70 production. Fc receptors of freshly isolated
monocytes were blocked, and monocytes (1.25  106/
ml) were subsequently preincubated with Abs against
human IL-10 (aIL10; 10 g/ml) or IL-10R (aIL10R; 10
g/ml) for 1 h before stimulation with R848 (0.5 g/ml)
and LPS (1 g/ml). The means  SEM of four inde-
pendent experiments are shown. The data are normal-
ized to R848 plus LPS plus anti-IL-10 plus anti-IL-10R-
stimulated IL-12p70 concentrations representing 100%
(1019 pg/ml 387). , p 0.012 for LPS (anti-IL-10
plus anti-IL-10R) and 0.008 for LPS plus R848  (anti-
IL-10 plus anti-IL-10R), respectively. , p  0.0005
for R848  (anti-IL-10 plus anti-IL-10R).
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In contrast with the human primary monocytes that exclusively
express TLR8, MDCs express both TLR7 and TLR8. To date, it
remains unclear whether TLR7 or TLR8 is involved in synergistic
activation of MDCs via LPS and R848 (33, 34, 44). In this work
we demonstrate for the first time that the single ligation of TLR8
independent of TLR7 is sufficient for cooperation with TLR4. An
additional advantage of analyzing TLR requirements in monocytes
is the virtual absence of IL-12p70 upon stimulation with single
TLR ligands, whereas a higher background of IL-12 production
upon single TLR ligand stimulation obscures this effect in MoDCs.
In contrast with mice, CpG DNA does not support priming of Th
cell responses in primates (45). One could speculate that this defect
in priming Th cell responses is due to the failure of CpG DNA to
directly induce IL-12p70 in human myeloid cells. In the human
immune system, TLR9, the receptor for CpG DNA, is expressed in
B cells and PDCs, but not in cells of the myeloid lineage (10, 46).
B cells and PDCs only produce IL-12 upon simultaneous stimu-
lation with CpG DNA and Th cell-derived CD40L (10, 12). Our
results now demonstrate that murine myeloid cells are not the only
cells capable of T cell-independent IL-12p70 production upon ap-
propriate microbial stimulation, but human myeloid cells can also
do this if they receive combined stimulation via TLR4 and TLR3
together with TLR7 or TLR8. Further studies need to examine
whether there are conditions under which stimulation with TLR7/8
alone is sufficient to elicit IL-12p70 production in human myeloid
cells. Our preliminary results show that, in the human immune
system, recognition of certain formulations of microbial RNA, the
natural ligand for TLR8, may serve this purpose.
Because the TLR4 ligand LPS is only expressed by Gram-neg-
ative bacteria, the question arises of how whole Gram-positive
bacteria are capable of triggering IL-12p70 production. We ad-
dressed this issue by testing synthetic TLR2 ligands that are
mainly expressed in cell walls of Gram-positive bacteria. To our
surprise, the combination of TLR2 ligands with either R848 or
LPS failed to induce IL-12p70 in human monocytes. To explain
IL-12p70 induction by Gram-positive bacteria, one could speculate
that whole bacteria, by providing microbial molecules at higher
density, represent a stronger stimulus for TLR2, or that additional
receptors are involved that may not yet have been identified.
There are a number of mechanisms, including TGF- and IL-10,
that inhibit IL-12 production (47–49). Furthermore, there is evi-
dence that prostaglandin E2 and other Gs-linked receptors inter-
fere with IL-12 secretion (50, 51). Our results confirm a key role
for IL-10 in inhibiting TLR-induced IL-12p70 production. Neu-
tralization of IL-10 enhanced IL-12p70 production in all condi-
tions tested. In this context, it is noteworthy that IL-10 inhibits
genes activated through the TLR-induced TRIF-dependent path-
way (52–54). In our hands, R848 supports LPS-induced IL-12p70
by decreasing LPS-stimulated IL-10 production.
Most viruses and many bacterial strains have been shown to
induce type I IFN production. A recent study performed in IFN-R
knockout mice provided evidence for the requirement of IFN-
priming and STAT1 activation for subsequent IL-12p70 secretion
in murine bone marrow-derived DCs (33). Furthermore, a report
from Hermann et al. (18) and two other studies (53, 54) claimed
that IL-10 inhibits LPS-induced IFN- production. Based on these
studies, we speculated that the costimulation of R848 with recom-
binant type I IFN could substitute for LPS-induced autocrine re-
lease of IFN- in our experimental setting. However, we found
that although the addition of type I IFN was insufficient to support
TLR4- or TLR8-induced IL-12p70 production in our hands, block-
ing of the IFN-R abolished IL-12p70 secretion in monocytes
upon combined stimulation with TLR4 and TLR8. These findings
indicate that type I IFN is required but not sufficient for IL-12p70
release by TLR4 and TLR8.
Autoimmune diseases are known to be triggered by bacterial
and viral infections. We postulate that the induction of IL-12p70
through synergistic activation via TLR4 and TLR8 as seen in the
present study could contribute to autoimmunity. The pathogenic
mechanisms leading to autoimmune disease may involve elevated
serum concentrations of type I IFNs, insufficient clearance of ap-
optotic particles, and recognition of endogenous RNA. During an
infection of a predisposed individual, the presence of LPS in the
serum may initiate the shift to a Th1 response by synergizing with
endogenous RNA and subsequently triggering the release of the
potentially harmful Th1 cytokine IL-12p70 from monocytes and
MDCs.
In conclusion, combined activation of myeloid cells via TLR4
and TLR8 offers the following advantages over single TLR stim-
ulation: 1) the key Th1 cytokine IL-12p70 is induced; 2) the ratio
of IL-12p70 to proinflammatory cytokines is increased in favor of
IL-12p70 and a Th1 response; and 3) a reduction in the dose
needed to support strong Th1 responses will lead to reduced sys-
temic toxicities as compared with single TLR ligands. Combined
TLR4 and TLR8-mediated stimulation may lead to improved strat-
egies for immunotherapy of cancer, viral infection, and allergies.
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